Generalized Pustular Psoriasis in Pregnancy: Current and Future Treatments

Menter A, Van Voorhees AS, Hsu S. Pustular psoriasis: a narrative review of recent developments in pathophysiology and therapeutic options. Dermatol Ther (Heidelb). 2021;11:1917–29.

PubMed  PubMed Central  Article  Google Scholar 

Genovese G, Moltrasio C, Cassano N, Maronese CA, Vena GA, Marzano AV. Pustular psoriasis: from pathophysiology to treatment. Biomedicines. 2021;9:1746.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Benjegerdes KE, Hyde K, Kivelevitch D, Mansouri B. Pustular psoriasis: pathophysiology and current treatment perspectives. Psoriasis (Auckl). 2016;6:131–44.

CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Jin H. Update on the aetiology and mechanisms of generalized pustular psoriasis. Eur J Dermatol. 2021;31:602–8.

CAS  PubMed  Article  Google Scholar 

Collamer AN, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum. 2010;40(3):233–40.

CAS  PubMed  Article  Google Scholar 

Dai Y-X, Chen C-C. Flare-up of pustular psoriasis after ustekinumab therapy: case report and literature review. Dermatol Sin. 2018;36:222–5.

Article  Google Scholar 

Namazi N, Dadkhahfar S. Impetigo herpetiformis: review of pathogenesis, complication, and treatment. Dermatol Res Pract. 2018;2018:5801280.

PubMed  PubMed Central  Article  Google Scholar 

Trivedi MK, Vaughn AR, Murase JE. Pustular psoriasis of pregnancy: current perspectives. Int J Womens Health. 2018;10:109–15.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Vena GA, Cassano N, Bellia G, Colombo D. Psoriasis in pregnancy: challenges and solutions. Psoriasis (Auckl). 2015;5:83–95.

CAS  PubMed  PubMed Central  Google Scholar 

Sugiura K, Takemoto A, Yamaguchi M, Takahashi H, Shoda Y, Mitsuma T, et al. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J Investig Dermatol. 2013;133(11):2514–21.

CAS  PubMed  Article  Google Scholar 

Kinoshita M, Ogawa Y, Takeichi T, Okamoto T, Osada A, Shimada S, et al. Impetigo herpetiformis with IL-36RN mutation successfully treated with secukinumab. Eur J Dermatol. 2018;28(3):381–2.

PubMed  Article  Google Scholar 

Ogrum A, Takci Z, Seckin HY, Cetin E. Treatment resistant impetigo herpetiformis treated with infliximab. Dermatol Ther. 2019;32(2): e12839.

PubMed  Article  Google Scholar 

Yamashita T, Hamada T, Maruta Y, Kajita A, Hirai Y, Morizane S, et al. An effective and promising treatment with adalimumab for impetigo herpetiformis with postpartum flare-up. Int J Dermatol. 2019;58(3):350–3.

PubMed  Article  Google Scholar 

Kondo RN, Araújo FM, Pereira AM, Lopes VC, Martins LM. Pustular psoriasis of pregnancy (impetigo herpetiformis)—case report. An Bras Dermatol. 2013;88(6 Suppl 1):186–9.

PubMed  PubMed Central  Article  Google Scholar 

Iwasaki A, Kawakami H, Okubo Y. Granulocyte/monocyte adsorption apheresis as a novel therapeutic approach in the treatment of an impetigo herpetiformis case. Ther Apher Dial. 2018;22(4):414–6.

PubMed  Article  Google Scholar 

Chhabra G, Chanana C, Verma P, Saxena A. Impetigo herpetiformis responsive to secukinumab. Dermatol Ther. 2019;32(5): e13040.

PubMed  Article  Google Scholar 

Mohaghegh F, Galehdari H, Rezaie M. Pustular psoriasis of pregnancy in early first trimester: a case report. Clin Case Rep. 2021;9(7): e04438.

PubMed  PubMed Central  Google Scholar 

Fujita H, Terui T, Hayama K, Akiyama M, Ikeda S, Mabuchi T, et al. Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP. J Dermatol. 2018;45:1235–70.

PubMed  Article  Google Scholar 

Navarini AA, Burden AD, Capon F, Mrowietz U, Puig L, Köks S, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 2017;31:1792–9.

CAS  PubMed  Article  Google Scholar 

Halevy S, Kardaun SH, Davidovici B, Wechsler J. EuroSCAR and RegiSCAR study group. The spectrum of histopathological features in acute generalized exanthematous pustulosis: a study of 102 cases. Br J Dermatol. 2010;163:1245–52.

CAS  PubMed  Article  Google Scholar 

Feldmeyer L, Heidemeyer K, Yawalkar N. Acute generalized exanthematous pustulosis: pathogenesis, genetic background, clinical variants and therapy. Int J Mol Sci. 2016;17:1214.

PubMed Central  Article  CAS  Google Scholar 

Navarini AA, Valeyrie-Allanore L, Setta-Kaffetzi N, Barker JN, Capon F, Creamer D, et al. Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis. J Investig Dermatol. 2013;133:1904–7.

CAS  PubMed  Article  Google Scholar 

Navarini AA, Simpson MA, Borradori L, Yawalkar N, Schlapbach C. Homozygous missense mutation in IL36RN in generalized pustular dermatosis with intraoral involvement compatible with both AGEP and generalized pustular psoriasis. JAMA Dermatol. 2015;151:452–3.

PubMed  Article  Google Scholar 

Rogel-Vence M, González-Ruiz L, Santiago Sánchez-Mateos JL. Annular pustular psoriasis. Med Clin. 2020;155:326.

Article  Google Scholar 

Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, et al. Clinical and genetic differences between pustular psoriasis subtypes. J Allergy Clin Immunol. 2019;143:1021–6.

PubMed  PubMed Central  Article  Google Scholar 

Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, et al. Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis. N Engl J Med. 2019;380:981–3.

PubMed  Article  Google Scholar 

Choon SE, Lebwohl MG, Marrakchi S, Burden AD, Tsai TF, Morita A, et al. Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare. BMJ Open. 2021;11(3): e043666.

PubMed  PubMed Central  Article  Google Scholar 

Komine M, Morita A. Generalized pustular psoriasis: current management status and unmet medical needs in Japan. Expert Rev Clin Immunol. 2021;17(9):1015–27.

CAS  PubMed  Article  Google Scholar 

Ohnishi H, Kadowaki T, Mizutani Y, Nishida E, Tobita R, Abe N, et al. Genetic background and therapeutic response in generalized pustular psoriasis patients treated with granulocyte and monocyte adsorption apheresis. Eur J Dermatol. 2018;28:108–11.

CAS  PubMed  Google Scholar 

Samotij D, Szczęch J, Reich A. Generalized pustular psoriasis: divergence of innate and adaptive immunity. Int J Mol Sci. 2021;22(16):9048.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Hussain S, Berki DM, Choon S-E, Burden AD, Allen MH, Arostegui JI, et al. IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis. J Allergy Clin Immunol. 2015;135(4):1067-1070.e9.

CAS  PubMed  Article  Google Scholar 

Wang T-S, Chiu H-Y, Hong J-B, Chan C-C, Lin S-J, Tsai T-F. Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients. Arch Dermatol Res. 2016;308(1):55–63.

CAS  PubMed  Article  Google Scholar 

Liu ZJ, Tian YT, Shi BY, Zhou Y, Jia XS. Association between mutation of interleukin 36 receptor antagonist and generalized pustular psoriasis: a PRISMA-compliant systematic review and meta-analysis. Medicine. 2020;99: e23068.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Mössner R, Wilsmann-Theis D, Oji V, Gkogkolou P, Löhr S, Schulz P, et al. The genetic basis for most patients with pustular skin disease remains elusive. Br J Dermatol. 2018;178:740–8.

PubMed  Article  CAS  Google Scholar 

Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei XY, Fraitag S, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365:620–8.

CAS  PubMed  Article  Google Scholar 

Onoufriadis A, Simpson MA, Pink AE, Di Meglio P, Smith CH, Pullabhatla V, et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet. 2011;89:432–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Yoshikawa M, Rokunohe D, Kimura A, Takahashi M, Korekawa A, Nakajima K, et al. Significance of IL36RN mutation analyses in the management of impetigo herpetiformis: a case report and review of published cases. J Dermatol. 2021;48:699–702.

CAS  PubMed  Article  Google Scholar 

Sugiura K, Muto M, Akiyama M. CARD14 c.526G>C (p.Asp176His) is a significant risk factor for generalized pustular psoriasis with psoriasis vulgaris in the Japanese cohort. J Investig Dermatol. 2014;134(6):1755–7.

CAS  PubMed  Article  Google Scholar 

Fujii K, Takahashi T, Matsuyama K, Fujii A, Mizutani Y, Ohnishi H, et al. Impetigo herpetiformis with a CARD14 Thr79Ile variant successfully treated with granulocyte and monocyte adsorption apheresis. J Dermatol. 2020;47(3):e84–5.

PubMed  Google Scholar 

留言 (0)

沒有登入
gif